Chemomab Therapeutics Ltd Share Price Today: Live Updates & Key Insights
Chemomab Therapeutics Ltd share price today is $1.75, up -7.77%. The stock opened at $1.87 against the previous close of $1.93, with an intraday high of $1.9 and low of $1.69.
Chemomab Therapeutics Ltd Share Price Chart
Chemomab Therapeutics Ltd
Chemomab Therapeutics Ltd Share Price Performance
Chemomab Therapeutics Ltd Institutional Holdings
Chemomab Therapeutics Ltd Market Status
Chemomab Therapeutics Ltd Fundamentals
Market Cap 10.96 M
PB Ratio 0.9755
PE Ratio 0.0
Enterprise Value 0.90 M
Total Assets 16.96 M
Volume 71173
Chemomab Therapeutics Ltd Company Financials
About Chemomab Therapeutics Ltd & investment objective
Company Information Chemomab Therapeutics Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of therapeutics for the treatment of fibrotic and inflammatory diseases in the United States. Its lead product candidate is Nebokitug, a humanized monoclonal antibody attenuates the basic function of CCL24 that has completed phase 2 clinical trial for the treatment of primary sclerosing cholangitis (PSC); and is in phase 2 clinical trial to treat systemic sclerosis (SSc). Chemomab Therapeutics Ltd. was founded in 2011 and is based in Tel Aviv-Yafo, Israel.
Organisation Biotechnology
Employees 0
Industry Biotechnology
CEO Dr. Adi Mor George Ph.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Chemomab Therapeutics Ltd FAQs
What is the share price of Chemomab Therapeutics Ltd today?
The current share price of Chemomab Therapeutics Ltd is $1.75.
Can I buy Chemomab Therapeutics Ltd shares in India?
Yes, Indian investors can buy Chemomab Therapeutics Ltd shares by opening an international trading and demat account with Motilal Oswal.
How to buy Chemomab Therapeutics Ltd shares in India?
You can easily invest in Chemomab Therapeutics Ltd shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Chemomab Therapeutics Ltd shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Chemomab Therapeutics Ltd.
Can I buy fractional shares of Chemomab Therapeutics Ltd?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Chemomab Therapeutics Ltd?
Chemomab Therapeutics Ltd has a market cap of $10.96 M.
In which sector does Chemomab Therapeutics Ltd belong?
Chemomab Therapeutics Ltd operates in the Biotechnology sector.
What documents are required to invest in Chemomab Therapeutics Ltd stocks?
To invest, you typically need:
What is the PE and PB ratio of Chemomab Therapeutics Ltd?
The PE ratio of Chemomab Therapeutics Ltd is N/A and the PB ratio is 0.98.